Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure.
暂无分享,去创建一个
[1] R. DeFronzo,et al. FGF21 Contributes to Metabolic Improvements Elicited by Exenatide and Pioglitazone in Patients with Type 2 Diabetes. , 2022, American journal of physiology. Endocrinology and metabolism.
[2] C. Kendall,et al. Systematic review and meta-analysis examining the relationship between postprandial hypotension, cardiovascular events, and all-cause mortality , 2022, The American journal of clinical nutrition.
[3] M. Horowitz,et al. Effects of age on blood pressure and heart rate responses to whey protein in younger and older men , 2021, Journal of the American Geriatrics Society.
[4] S. Oparil,et al. The Story of the Silent Killer , 2020, Current Hypertension Reports.
[5] A. Nakashima,et al. Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated Dilation Japan (FMD-J) study , 2020, BMJ open diabetes research & care.
[6] K. Izawa,et al. Postprandial Blood Pressure Decrease in Patients with Type 2 Diabetes and Mild or Severe Cardiac Autonomic Dysfunction , 2019, International journal of environmental research and public health.
[7] K. Tsintzas,et al. FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans , 2017, The Journal of clinical endocrinology and metabolism.
[8] K. Lam,et al. Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis , 2017, Endocrinology and metabolism.
[9] Yun Zhao,et al. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status. , 2017, Nutrition.
[10] C. Bondor,et al. The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients , 2017, International Urology and Nephrology.
[11] M. Soares,et al. Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults , 2016, Redox biology.
[12] W. Shou,et al. FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats , 2016, Scientific Reports.
[13] S. Chanprasertyothin,et al. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading , 2015, Clinical endocrinology.
[14] J. Son,et al. Effects of the amount of rice in meals on postprandial blood pressure in older people with postprandial hypotension: a within-subjects design. , 2015, Journal of clinical nursing.
[15] H. Fu,et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. , 2013, Cell metabolism.
[16] L. Ferrucci,et al. Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults , 2013, Journal of Human Hypertension.
[17] Chaoming Wu,et al. Dynamic change of serum FGF21 levels in response to glucose challenge in human. , 2012, The Journal of clinical endocrinology and metabolism.
[18] Y. Bao,et al. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. , 2011, Clinical chemistry.
[19] M. Martínez-Chantar,et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. , 2010, Gastroenterology.
[20] M. Soares,et al. Postprandial hypotension in older Australians: Relationship to glycaemia and habitual food intake , 2007 .
[21] W. Pan,et al. The fasting polypeptide FGF21 can enter brain from blood , 2007, Peptides.
[22] R. O’Brien,et al. A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .
[23] J. Shaw,et al. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[24] D. Bloomfield,et al. Upright Posture and Postprandial Hypotension in Elderly Persons , 2000, Annals of Internal Medicine.
[25] T. Ogihara,et al. Mechanisms mediating postprandial blood pressure reduction in young and elderly subjects. , 1996, American journal of hypertension.
[26] L. Lipsitz,et al. Postprandial Hypotension: Epidemiology, Pathophysiology, and Clinical Management , 1995, Annals of Internal Medicine.
[27] N. Christensen,et al. Central hemodynamic changes after ingestion of a meal in patients with coronary artery disease. , 1989, Archives of internal medicine.
[28] D. B. Zilversmit. Atherogenesis: a postprandial phenomenon. , 1979, Circulation.